Filter News

News By Country

None Found

News By Tag

March 2025
Mo	Su	Sa	Fr	Th	We	Tu
10	9	8	7	6	5	4

Public Company News

Business Press Releases

Ophthalmic Press Releases

Topics Locations Industries Dates

IVIEW Therapeutics Inc. Announces Dosing of First Patient in Phase 1/2 Clinical Trial of IVW-1001 for Dry Eye Disease

By IVIEW Therapeutics Inc.

IVIEW Therapeutics Inc., a clinical stage biotechnology company advancing innovative treatments for ocular diseases, proudly announces the dosing of the first patient in the Phase 1/2 clinical trial of IVW-1001 Ophthalmic Eyelid Wipe.

Page updated every 10 minutes

Most Viewed

Parma, Ohio To Honor First African-American Police Officer With Street Naming Ceremony - 1648 views

Post-Oscar Iftar Night Celebrates Academy Award-Winning Documentary No Other Land with a Packed House - 1371 views

Expansive Estate in South Texas Seeks New Vision, 147 Acres Up for Grabs - 1236 views

NASW Arkansas Secures Funding for Naloxone Hero Program to Combat Opioid Overdoses - 973 views

Dexter B. Jenkins: Championing Financial Literacy and Empowering Generational Wealth Through Faith-Based Guidance - 688 views

Top Monthly News

Liberty Theatre of Columbus, GA Centennial Gala In April Celebrates A Legacy Of Black Storytelling - 16673 views

MOXIE Theatre Unveils Bold New Brand Identity Aligned with Its Mission and Values - 16233 views

$15 Million in New Equity to Support Advanced Cancer Diagnostics, Personalized Immunotherapy, Treatments & Drug Discovery: Renovaro Stock Symbol: RENB - 6295 views

Hope Survives Officially Launches as a Nonprofit with a Bold Vision for Brain Injury Support - 2506 views

Parma, Ohio To Honor First African-American Police Officer With Street Naming Ceremony - 1648 views